<HashMap><database>ecrin-mdr-crc</database><scores/><additional><omics_type>Clinical</omics_type><study_start_year>2019</study_start_year><condition>colorectal cancer liver metastases</condition><disease>Colorectal Cancer Liver Metastases</disease><study_type>Interventional</study_type><full_dataset_link>https://newmdr.ecrin.org/Study/2688048</full_dataset_link><location>China</location><study_start_month>10</study_start_month><repository>ECRIN MDR</repository><study_status>Recruiting</study_status></additional><is_claimable>false</is_claimable><name>A multi-center prospective randomized study on postoperative hepatic arterial chemotherapy combined with systemic chemotherapy as adjuvant treatment after resection of colorectal liver metastases</name><description>Interventions: experimental group:FOLFOX +HAI;control group:2 years postoperative recurrence rate
Primary outcome(s): 2-year recurrence rate and 2-year intrahepatic recurrence rate
Study Design: Parallel</description><dates><creation>2019-10-15</creation></dates><accession>2688048</accession><cross_references><Chinese Clinical Trial Register>ChiCTR1900027090</Chinese Clinical Trial Register></cross_references></HashMap>